These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30783498)

  • 1.
    Nitsche C; Passioura T; Varava P; Mahawaththa MC; Leuthold MM; Klein CD; Suga H; Otting G
    ACS Med Chem Lett; 2019 Feb; 10(2):168-174. PubMed ID: 30783498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
    Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of the Zika virus protease NS2B-NS3.
    Voss S; Nitsche C
    Bioorg Med Chem Lett; 2020 Mar; 30(5):126965. PubMed ID: 31980339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses.
    Shin HJ; Kim MH; Lee JY; Hwang I; Yoon GY; Kim HS; Kwon YC; Ahn DG; Kim KD; Kim BT; Kim SJ; Kim C
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33800763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease.
    Su XC; Ozawa K; Qi R; Vasudevan SG; Lim SP; Otting G
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e561. PubMed ID: 19997625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through
    Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R
    J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.
    da Silva-Júnior EF; de Araújo-Júnior JX
    Bioorg Med Chem; 2019 Sep; 27(18):3963-3978. PubMed ID: 31351847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Agents against Flavivirus Protease: Prospect and Future Direction.
    Samrat SK; Xu J; Li Z; Zhou J; Li H
    Pathogens; 2022 Feb; 11(3):. PubMed ID: 35335617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Antiviral Peptides against the NS2B/NS3 Protease of Zika Virus.
    Hossain MS; Shovon MTI; Hasan MR; Hakim FT; Hasan MM; Esha SA; Tasnim S; Nazir MS; Akhter F; Ali MA; Halim MA
    ACS Omega; 2023 Sep; 8(38):35207-35218. PubMed ID: 37779969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
    Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D
    Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.
    Nie S; Zhao J; Wu X; Yao Y; Wu F; Lin YL; Li X; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    Eur J Med Chem; 2021 Dec; 225():113767. PubMed ID: 34450494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
    Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
    PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.